To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

ProDisc-C total disc arthroplasty vs ACDF in single-level cervical disc disease at 7 years

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
February 2016

ProDisc-C total disc arthroplasty vs ACDF in single-level cervical disc disease at 7 years

Vol: 5| Issue: 2| Number:49| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:1

ProDisc-C Total Disc Replacement Versus Anterior Cervical Discectomy and Fusion for Single-Level Symptomatic Cervical Disc Disease: Seven-Year Follow-up of the Prospective Randomized U.S. Food and Drug Administration Investigational Device Exemption Study

J Bone Joint Surg Am. 2015 Nov 4;97(21):1738-47

Contributing Authors:
ME Janssen JE Zigler JM Spivak RB Delamarter Darden BV 2nd B Kopjar

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

209 patients with single-level cervical degenerative disc disease were randomized to undergo either anterior cervical discectomy and fusion (ACDF) or total disc arthroplasty (with ProDisc-C). The purpose of this randomized controlled trial was to report the 7-year efficacy and safety outcomes of an FDA Investigational Device Exemption randomized controlled trial. The results at both 2 and 7 years ...

Join the Conversation

Please Login or Join to leave comments.